Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 210,247 | 209,100 | 227,891 | 227,894 | 253,199 |
| Receivables | 729,740 | 692,388 | 704,909 | 686,264 | 672,271 |
| Inventories | 933,214 | 958,233 | 998,012 | 1,011,269 | 988,955 |
| TOTAL | $2,378,077 | $2,304,585 | $2,367,830 | $2,337,815 | $2,325,156 |
| Non-Current Assets | |||||
| PPE Net | 551,734 | 533,985 | 537,856 | 528,778 | 522,745 |
| Intangibles | 3,390,032 | 3,375,420 | 3,322,640 | 3,353,302 | 3,354,036 |
| Other Non-Current Assets | 585,245 | 526,796 | 523,382 | 493,984 | 474,167 |
| TOTAL | $4,527,011 | $4,436,201 | $4,383,878 | $4,376,064 | $4,350,948 |
| Total Assets | $6,905,088 | $6,740,786 | $6,751,708 | $6,713,879 | $6,676,104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 202,395 | 177,048 | 150,756 | 161,896 | 196,003 |
| Accrued Expenses | 332,136 | 348,263 | 365,660 | 347,354 | 312,169 |
| TOTAL | $764,073 | $770,802 | $758,533 | $761,691 | $732,714 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,216,769 | 1,351,511 | 1,431,234 | 1,575,963 | 1,790,689 |
| Deferred Revenues | 148,897 | 146,718 | 138,072 | 141,043 | 133,909 |
| Other Non-Current Liabilities | 225,700 | 158,933 | 222,202 | 221,826 | 204,231 |
| TOTAL | $1,659,161 | $1,719,608 | $1,863,272 | $2,019,679 | $2,205,263 |
| Total Liabilities | $2,423,234 | $2,490,410 | $2,621,805 | $2,781,370 | $2,937,977 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 147,089 | 147,092 | 147,071 | 146,931 | 146,909 |
| Common Shares | 588 | 588 | 588 | 588 | 588 |
| Retained earnings | 4,539,963 | 4,401,841 | 4,253,016 | 4,088,057 | 3,920,197 |
| Other shareholders' equity | -208,615 | -320,404 | -272,784 | -262,133 | -270,424 |
| TOTAL | $4,481,854 | $4,250,376 | $4,129,903 | $3,932,509 | $3,738,127 |
| Total Liabilities And Equity | $6,905,088 | $6,740,786 | $6,751,708 | $6,713,879 | $6,676,104 |